Halodine® Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19)

FORT LAUDERDALE, Fla., May 13, 2020 /PRNewswire/ -- Veloce BioPharma LLC reports today that their Halodine® Antiseptics have demonstrated rapid viricidal efficacy against SARS-CoV-2, the virus that causes COVID-19. Halodine® is a proprietary povidone-iodine antiseptic developed in...

from PR Newswire: https://ift.tt/3fQqU9U